Advertisement
Screener

XBIOTECH INC. (XBIT) Net Cash Provided by (Used in) Investing Activities, Continuing Operations

1.3 / 5 stars · 14/53 Roast Me

XBIOTECH INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations

XBIOTECH INC. (XBIT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$890.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.

Discontinued › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-08

  • 2017-06-30: Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month -$890.00K.
  • 2016-06-30: Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month -$8.77M.
Period endNet Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month
2017-06-30-$890.00K
10-Q · filed 2017-08-08
2016-06-30-$8.77M
10-Q · filed 2017-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95